Nuveen’s Pfizer PFE Stock Holding History

Nuveen’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-26,350	Closed	-$1K	–	3336
2020 Q2	$1K	Buy	+26,350	New	+$895K	﹤0.01%	3263
2016 Q1	–	Sell	-5,270	Closed	-$161K	–	1473
2015 Q4	$161K	Sell	5,270 -6,324	-55%	-$199K	﹤0.01%	1458
2015 Q3	$346K	Hold	11,594	–	–	﹤0.01%	1395
2015 Q2	$369K	Sell	11,594 -10,540	-48%	-$344K	﹤0.01%	1433
2015 Q1	$731K	Sell	22,134 -54,808	-71%	-$1.74M	﹤0.01%	1270
2014 Q4	$2.27M	Buy	76,942 +1,054	+1%	+$30.2K	0.01%	789
2014 Q3	$2.13M	Hold	75,888	–	–	0.01%	797
2014 Q2	$2.14M	Buy	75,888 +2,108	+3%	+$60.1K	0.01%	795
2014 Q1	$2.25M	Sell	73,780 -36,890	-33%	-$1.1M	0.01%	760
2013 Q4	$3.22M	Sell	110,670 -18,972	-15%	-$552K	0.02%	617
2013 Q3	$4.02M	Sell	129,642 -35,836	-22%	-$975K	0.03%	574
2013 Q2	$4.4M	Buy	+165,478	New	+$4.57M	0.03%	542

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nuveen's PFE Position: Q2 2026 in Review

Nuveen increased its Pfizer (PFE) stake by 9.6% in Q2 2026, buying an estimated $33.1M and bringing the position to 14,445,787 shares worth $348M. The position accounts for 0.08% of the portfolio, ranked #181.

Nuveen first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.66B in Q4 2021. 2,839 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Nuveen held 14,445,787 shares of Pfizer worth $348M as of Q2 2026.
Nuveen bought 1,267,126 Pfizer shares in Q2 2026, an estimated $33.1M.
Pfizer made up 0.08% of Nuveen's portfolio in Q2 2026, its #181 holding.
Nuveen first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Nuveen's Pfizer position peaked at $1.66B in Q4 2021.
2,839 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.